MoneyWorks4Me

Genomic Valley Biotech informs about disclosure

13 May 2022 Evaluate

Genomic Valley Biotech has confirmed that the company do not fall under the ambit of 'Large Entities' as per the SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 regarding the Fund raising of Debt Securities by Large Entities and do not have an outstanding long-term borrowing of Rs 100 crores or above with original maturity of more than one year.

The above information is a part of company’s filings submitted to BSE.

Peers